Market Analysis and Insights: Global Transdermal Drug Patches Market
Due to the COVID-19 pandemic, the global Transdermal Drug Patches market size was value at US$ 6,680.25 million in 2021 and is forecast to be a readjusted size of US$ 7630.01 million by 2028 with a CAGR of 1.86% during the forecast period 2022-2028.
The global main manufacturers of Transdermal Drug Patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, and IBSA Group, etc. In 2021, the global six largest players have a share approximately 41.80% in terms of revenue.
The North America Transdermal Drug Patches market size was US$ 3,340.28 million in 2021, while China was about US$ 288.23 million. The proportion of the China was 4.31% in 2021 and it is predicted that the share will reach 8.89% in 2028, trailing a CAGR of 12.34% through the analysis period.
Fully considering the economic change by the COVID-19, Methyl Salicylate-based Patch accounting for 13.17% of the Transdermal Drug Patches global market in 2021, is projected to value US$ 800.46 million by 2028, growing at a revised -0.91% CAGR from 2022 to 2028. While Rx Channel segment is altered to an 1.77% CAGR throughout this forecast period and will hold a share about 93.49% in 2028.
Global Transdermal Drug Patches Scope and Market Size
The global Transdermal Drug Patches market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories
By Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
SEA
Europe
Germany
France
U.K.
Italy
Spain
South America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
UAE
Turkey
South Africa
- 1 TRANSDERMAL DRUG PATCHES MARKET OVERVIEW
- 1.1 TRANSDERMAL DRUG PATCHES PRODUCT OVERVIEW
- 1.2 TRANSDERMAL DRUG PATCHES MARKET SEGMENT BY TYPE
- 1.2.1 METHYL SALICYLATE-BASED PATCH
- 1.2.2 RIVASTIGMINE TRANSDERMAL PATCH
- 1.2.3 FENTANYL TRANSDERMAL PATCH
- 1.2.4 LIDOCAINE PATCH
- 1.2.5 DICLOFENAC PATCH
- 1.2.6 NICOTINE TRANSDERMAL PATCH
- 1.3 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE BY TYPE
- 1.3.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE OVERVIEW BY TYPE (2017-2028)
- 1.3.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022)
- 1.3.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY TYPE (2023-2028)
- 1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE
- 1.4.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.2 EUROPE TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.3 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.4 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.5 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
- 2 TRANSDERMAL DRUG PATCHES MARKET COMPETITION BY COMPANY
- 2.1 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES SALES (2017-2022)
- 2.2 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES REVENUE (2017-2022)
- 2.3 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES PRICE (2017-2022)
- 2.4 GLOBAL TOP MANUFACTURERS TRANSDERMAL DRUG PATCHES MANUFACTURING BASE DISTRIBUTION, SALES AREA, PRODUCT TYPE
- 2.5 TRANSDERMAL DRUG PATCHES MARKET COMPETITIVE SITUATION AND TRENDS
- 2.5.1 TRANSDERMAL DRUG PATCHES MARKET CONCENTRATION RATE
- 2.5.2 GLOBAL 5 LARGEST MANUFACTURERS BY TRANSDERMAL DRUG PATCHES REVENUE IN 2021
- 2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN TRANSDERMAL DRUG PATCHES AS OF 2021)
- 2.7 KEY MANUFACTURERS TRANSDERMAL DRUG PATCHES PRODUCT OFFERED
- 2.8 MERGERS & ACQUISITIONS, EXPANSION
- 3 TRANSDERMAL DRUG PATCHES STATUS AND OUTLOOK BY REGION
- 3.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE AND CAGR BY REGION: 2017 VS 2022 VS 2028
- 3.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY REGION
- 3.2.1 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2017-2022)
- 3.2.2 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2017-2022)
- 3.2.3 GLOBAL TRANSDERMAL DRUG PATCHES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2017-2022)
- 3.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY REGION
- 3.3.1 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2023-2028)
- 3.3.2 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2023-2028)
- 3.3.3 GLOBAL TRANSDERMAL DRUG PATCHES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2023-2028)
- 4 TRANSDERMAL DRUG PATCHES BY APPLICATION
- 4.1 TRANSDERMAL DRUG PATCHES MARKET SEGMENT BY APPLICATION
- 4.1.1 RX CHANNEL
- 4.1.2 OTC CHANNEL
- 4.2 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE BY APPLICATION
- 4.2.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE OVERVIEW BY APPLICATION (2017-2028)
- 4.2.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022)
- 4.2.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
- 4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION
- 4.3.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.2 EUROPE TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.3 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.4 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.5 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
- 5 NORTH AMERICA TRANSDERMAL DRUG PATCHES BY COUNTRY
- 5.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
- 5.1.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
- 5.1.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
- 5.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
- 5.2.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
- 5.2.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)
- 6 EUROPE TRANSDERMAL DRUG PATCHES BY COUNTRY
- 6.1 EUROPE TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
- 6.1.1 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
- 6.1.2 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
- 6.2 EUROPE TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
- 6.2.1 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
- 6.2.2 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)
- 7 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES BY REGION
- 7.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY REGION
- 7.1.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2017-2022)
- 7.1.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2017-2022)
- 7.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY REGION
- 7.2.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2023-2028)
- 7.2.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2023-2028)
- 8 SOUTH AMERICA TRANSDERMAL DRUG PATCHES BY COUNTRY
- 8.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
- 8.1.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
- 8.1.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
- 8.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
- 8.2.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
- 8.2.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)
- 9 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES BY COUNTRY
- 9.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
- 9.1.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
- 9.1.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
- 9.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
- 9.2.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
- 9.2.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)
- 10 COMPANY PROFILES AND KEY FIGURES IN TRANSDERMAL DRUG PATCHES BUSINESS
- 10.1 HISAMITSU PHARMACEUTICAL
- 10.1.1 HISAMITSU PHARMACEUTICAL CORPORATION INFORMATION
- 10.1.2 HISAMITSU PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW
- 10.1.3 HISAMITSU PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.1.4 HISAMITSU PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.2 JOHNSON & JOHNSON
- 10.2.1 JOHNSON & JOHNSON CORPORATION INFORMATION
- 10.2.2 JOHNSON & JOHNSON INTRODUCTION AND BUSINESS OVERVIEW
- 10.2.3 JOHNSON & JOHNSON TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.2.4 JOHNSON & JOHNSON TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.3 MYLAN
- 10.3.1 MYLAN CORPORATION INFORMATION
- 10.3.2 MYLAN INTRODUCTION AND BUSINESS OVERVIEW
- 10.3.3 MYLAN TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.3.4 MYLAN TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.4 UCB PHARMA
- 10.4.1 UCB PHARMA CORPORATION INFORMATION
- 10.4.2 UCB PHARMA INTRODUCTION AND BUSINESS OVERVIEW
- 10.4.3 UCB PHARMA TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.4.4 UCB PHARMA TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.5 NOVARTIS
- 10.5.1 NOVARTIS CORPORATION INFORMATION
- 10.5.2 NOVARTIS INTRODUCTION AND BUSINESS OVERVIEW
- 10.5.3 NOVARTIS TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.5.4 NOVARTIS TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.6 TEVA PHARMACEUTICAL
- 10.6.1 TEVA PHARMACEUTICAL CORPORATION INFORMATION
- 10.6.2 TEVA PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW
- 10.6.3 TEVA PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.6.4 TEVA PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.7 BEIJING TIDE PHARMACEUTICAL
- 10.7.1 BEIJING TIDE PHARMACEUTICAL CORPORATION INFORMATION
- 10.7.2 BEIJING TIDE PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW
- 10.7.3 BEIJING TIDE PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.7.4 BEIJING TIDE PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.8 CHATTEM
- 10.8.1 CHATTEM CORPORATION INFORMATION
- 10.8.2 CHATTEM INTRODUCTION AND BUSINESS OVERVIEW
- 10.8.3 CHATTEM TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.8.4 CHATTEM TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.9 NITTO DENKO
- 10.9.1 NITTO DENKO CORPORATION INFORMATION
- 10.9.2 NITTO DENKO INTRODUCTION AND BUSINESS OVERVIEW
- 10.9.3 NITTO DENKO TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.9.4 NITTO DENKO TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.10 GRÜNENTHAL
- 10.10.1 GRÜNENTHAL CORPORATION INFORMATION
- 10.10.2 GRÜNENTHAL INTRODUCTION AND BUSINESS OVERVIEW
- 10.10.3 GRÜNENTHAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.10.4 GRÜNENTHAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.11 MUNDIPHARMA
- 10.11.1 MUNDIPHARMA CORPORATION INFORMATION
- 10.11.2 MUNDIPHARMA INTRODUCTION AND BUSINESS OVERVIEW
- 10.11.3 MUNDIPHARMA TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.11.4 MUNDIPHARMA TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.12 GSK
- 10.12.1 GSK CORPORATION INFORMATION
- 10.12.2 GSK INTRODUCTION AND BUSINESS OVERVIEW
- 10.12.3 GSK TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.12.4 GSK TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.13 LUYE PHARMA GROUP
- 10.13.1 LUYE PHARMA GROUP CORPORATION INFORMATION
- 10.13.2 LUYE PHARMA GROUP INTRODUCTION AND BUSINESS OVERVIEW
- 10.13.3 LUYE PHARMA GROUP TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.13.4 LUYE PHARMA GROUP TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.14 BAYER
- 10.14.1 BAYER CORPORATION INFORMATION
- 10.14.2 BAYER INTRODUCTION AND BUSINESS OVERVIEW
- 10.14.3 BAYER TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.14.4 BAYER TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.15 IBSA GROUP
- 10.15.1 IBSA GROUP CORPORATION INFORMATION
- 10.15.2 IBSA GROUP INTRODUCTION AND BUSINESS OVERVIEW
- 10.15.3 IBSA GROUP TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.15.4 IBSA GROUP TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 10.16 DR REDDY’S LABORATORIES
- 10.16.1 DR REDDY’S LABORATORIES CORPORATION INFORMATION
- 10.16.2 DR REDDY’S LABORATORIES INTRODUCTION AND BUSINESS OVERVIEW
- 10.16.3 DR REDDY’S LABORATORIES TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
- 10.16.4 DR REDDY’S LABORATORIES TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
- 11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
- 11.1 TRANSDERMAL DRUG PATCHES KEY RAW MATERIALS
- 11.1.1 KEY RAW MATERIALS
- 11.1.2 RAW MATERIALS KEY SUPPLIERS
- 11.2 MANUFACTURING COST STRUCTURE
- 11.2.1 RAW MATERIALS
- 11.2.2 LABOR COST
- 11.2.3 MANUFACTURING EXPENSES
- 11.3 TRANSDERMAL DRUG PATCHES INDUSTRIAL CHAIN ANALYSIS
- 11.4 TRANSDERMAL DRUG PATCHES MARKET DYNAMICS
- 11.4.1 TRANSDERMAL DRUG PATCHES INDUSTRY TRENDS
- 11.4.2 TRANSDERMAL DRUG PATCHES MARKET DRIVERS
- 11.4.3 TRANSDERMAL DRUG PATCHES MARKET CHALLENGES
- 11.4.4 TRANSDERMAL DRUG PATCHES MARKET RESTRAINTS
- 12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS
- 12.1 SALES CHANNEL
- 12.2 TRANSDERMAL DRUG PATCHES DISTRIBUTORS
- 12.3 TRANSDERMAL DRUG PATCHES DOWNSTREAM CUSTOMERS
- 13 RESEARCH FINDINGS AND CONCLUSION
- 14 APPENDIX
- 14.1 RESEARCH METHODOLOGY
- 14.1.1 METHODOLOGY/RESEARCH APPROACH
- 14.1.2 DATA SOURCE
- 14.2 AUTHOR DETAILS
- 14.3 DISCLAIMER
- List of Tables
- Table 1. Global Transdermal Drug Patches Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
- Table 2. Global Transdermal Drug Patches Sales by Type (2017-2022) & (M Pieces)
- Table 3. Global Transdermal Drug Patches Sales Market Share in Volume by Type (2017-2022)
- Table 4. Global Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
- Table 5. Global Transdermal Drug Patches Sales Market Share in Value by Type (2017-2022)
- Table 6. Global Transdermal Drug Patches Price by Type (2017-2022) & (USD/Piece)
- Table 7. Global Transdermal Drug Patches Sales by Type (2023-2028) & (M Pieces)
- Table 8. Global Transdermal Drug Patches Sales Market Share in Volume by Type (2023-2028)
- Table 9. Global Transdermal Drug Patches Sales by Type (2023-2028) & (US$ Million)
- Table 10. Global Transdermal Drug Patches Sales Market Share in Value by Type (2023-2028)
- Table 11. Global Transdermal Drug Patches Price by Type (2023-2028) & (USD/Piece)
- Table 12. North America Transdermal Drug Patches Sales by Type (2017-2022) & (M Pieces)
- Table 13. North America Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
- Table 14. Europe Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
- Table 15. Europe Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
- Table 16. Asia-Pacific Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
- Table 17. Asia-Pacific Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
- Table 18. South America Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
- Table 19. South America Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
- Table 20. Middle East and Africa Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook